The latest round of opioid settlements are set to bring the Hoosier state nearly $17 million from drug companies across America. Oxycodone is the generic name for a range of opoid pain killing tablets.

News Release

INDIANAPOLIS — The latest round of opioid settlements are set to bring the Hoosier state nearly $17 million from drug companies across America.

The nationwide settlements total around $720 million across eight companies, according to Indiana Attorney General Todd Rokita. This latest resolution is the 11th reached by Indiana, with the state having received $1.1 billion over the past four years.

“Thousands of Hoosiers have lost their lives as a result of the opioid crisis,” Rokita said in a news release. “We can never undo that tragic loss of life, but we can hold accountable those responsible for contributing to the situations culminating in these deaths. That’s what these settlements are all about, and I’m proud of the work of our team.”

On Sunday, July 10, the settlement was announced, which was negotiated by California, Carolina, Colorado, New York, North Illinois, Oregon, Tennessee, Utah, and Virginia. Drug companies involved were Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan — now a part of Viatris — Sun and Zydus.

The settlement’s terms included the following:

• Companies involved in the settlement cannot incentivize employees with financial rewards or punishments based on number of opioids sold.
• Companies involved in the settlement cannot produce, promote or distribute products containing over 40 milligrams of oxycodone per pill. Coupons, discounts and rebates also cannot be offered for opioids.
• Funding, grants and lobbying related to opioids are also forbidden under the settlement.
• Finally, each company will submit to suspicious order monitoring, a condition comparable to those found in other opioid producer settlements.

Indivior, which primarily creates opioid addiction medicine, was also barred from producing opioid products for the next decade.

A similar settlement was reached by Rokita and 55 other attorneys in June with OxyContin maker Purdue Pharma and the Sackler family. The $7.4 billion legal resolution is the largest to date tied to the opioid crisis.

According the Attorney General’s Office, opioid prescriptions peaked in Indiana in 2012, with 112 opioid prescriptions for every 100 residents on average.